Can my telehealth company really sell camera-based vitals under my brand?

The question of whether a telehealth company can sell camera-based vitals under its own brand is no longer a technical one, it's a strategic one. With telehealth utilization stabilizing at 38 times pre-pandemic levels, the market has shifted from basic access to differentiated quality. For digital health founders and product managers, this means the features that were once novelties, like remote vital sign monitoring, are now table stakes. The real challenge is integrating these features in a way that builds brand equity and patient trust, rather than just adding a line item to a feature list. Successfully navigating this requires a deep understanding of the trade-offs between building proprietary technology, licensing an SDK, and adopting a comprehensive white-label platform.

"A 2023 survey found that while 87% of patients were satisfied with their telemedicine care, trust in the technology and the security of their data remain significant barriers to wider adoption." - Eagle Telemedicine, 2023

The strategic case for selling vitals under your own brand

For telehealth companies, the ability to telehealth sell vitals own brand represents a significant competitive advantage. It moves the conversation from "we also have vitals" to "our platform provides a seamless, trusted health monitoring experience." This is not just a matter of marketing; it's about patient experience and clinical utility. When a patient sees a consistent brand across every touchpoint, from the initial appointment booking to the vital sign scan, it reinforces trust and credibility in the provider.

However, achieving this seamless experience is complex. It involves more than just placing a logo on a user interface. The underlying technology must be robust, secure, and compliant. The user experience must be intuitive for a non-technical patient population. And the clinical data must be accurate and integrated smoothly into the electronic health record (EHR) and clinical workflow. Attempting to build this entire stack from the ground up is a multi-year, multi-million dollar effort fraught with technical and regulatory risks. This is why a growing number of digital health companies are turning to white-label solutions, which offer a proven, scalable path to market under their own brand identity.

A 2023 systematic review by researchers at the Universitas Indonesia confirmed that trust in the technology platform is a primary determinant of overall patient trust in telemedicine. This suggests that the decision of how to source your vitals technology is not just an IT decision, but a core component of your branding and patient acquisition strategy.

Integration Strategy	Time to Market	Brand Control	Technical Overhead
Build In-House	24-36 months	Full	Very High
License SDK	6-12 months	Partial	High
White-Label Platform	1-3 months	Full (Cosmetic)	Low
Referral Partner	<1 month	None	Very Low

Industry Applications

The demand for branded, integrated vitals is not uniform across the healthcare landscape. Different sectors have unique needs and a white-label approach allows a telehealth company to tailor its offering accordingly.

Virtual primary care & urgent care

For platforms that serve as the new "digital front door" for patients, brand consistency is critical. A patient seeking a virtual urgent care visit expects a cohesive experience.

• Seamless User Journey: The ability to check vital signs like heart rate, blood pressure, and respiratory rate directly within the branded virtual visit workflow, without downloading a separate app.
• Data-Driven Triage: Using baseline vitals to triage patients to the appropriate level of care, all under the trusted brand of the provider.
• Post-Visit Monitoring: Offering branded post-visit monitoring plans for patients with conditions that require follow-up.

Chronic disease management

Chronic care platforms require long-term patient engagement, and a consistent brand experience is crucial for maintaining it. Trust is built over time through reliable and easy-to-use tools.

• Longitudinal Data: Patients are more likely to consistently use a monitoring tool that is integrated into their primary care provider's platform.
• Customized Alerts: Configuring alerts and thresholds within the branded portal based on a patient's specific condition and care plan.
• Family & Caregiver Access: Providing a branded portal for family members and caregivers to view trends and receive updates, strengthening the circle of care.

Employer Wellness

Corporate wellness programs often use branded portals to drive employee engagement. Adding vitals monitoring can significantly increase the value proposition.

• Engagement & Gamification: Integrating vitals checks into wellness challenges and incentive programs.
• Health Risk Assessments: Using camera-based scans to provide a convenient, scalable way for employees to complete annual health risk assessments.

Current research and evidence

The move towards integrated, camera-based vitals is supported by a growing body of research. A key 2022 study by researchers at the University of Toronto (led by Kang Lee and Paul Zheng) demonstrated that transdermal optical imaging, a form of remote photoplethysmography (rPPG), could measure blood pressure with accuracy comparable to conventional cuff-based devices. This research, published in Circulation: Cardiovascular Imaging, was a turning point, providing clinical validation for the underlying technology.

Further studies have focused on the user experience and patient trust. A 2023 report from the American Hospital Association noted that patient comfort with telehealth is directly tied to the simplicity and reliability of the technology. When a platform is perceived as secure and easy to navigate, patients are more willing to trust the clinical information it provides. This has direct implications for companies looking to telehealth sell vitals own brand. An off-the-shelf, unbranded solution can create a disjointed experience that erodes patient confidence, while a fully branded, integrated platform enhances it. Research from Boral Agency in 2023 on healthcare branding reinforces this, showing that consistent branding builds the loyalty and retention essential for long-term patient relationships.

The future of branded telehealth vitals

The integration of camera-based vitals is just the beginning. The future lies in using this data to power more proactive and personalized care models, all delivered under the telehealth company's unique brand. As the technology evolves, we can expect to see the fusion of rPPG with AI-driven analytics to detect early signs of clinical deterioration, assess mental stress, and provide real-time feedback to patients.

For telehealth platforms, the strategic imperative will be to own the patient relationship. This will not be possible if the most innovative features are outsourced to third-party apps with competing brands. A white-label approach allows a company to incorporate recent features while ensuring that its brand remains at the center of the patient experience. The platform of the future is not just a collection of features; it's a trusted, branded ecosystem of care.

Frequently asked questions

Q: Is the technology behind camera-based vitals accurate enough for clinical use? A: Yes, the underlying technology, known as remote photoplethysmography (rPPG), has been validated in numerous peer-reviewed studies. For example, research from the University of Toronto (Lee & Zheng, 2022) found its accuracy for blood pressure to be comparable to traditional cuffs. However, accuracy is highly dependent on the quality of the vendor's algorithms, lighting conditions, and patient stability.

Q: What are the main differences between licensing a vitals SDK and using a white-label platform? A: An SDK (Software Development Kit) provides a set of tools to build the feature into your existing application. This offers deep integration but requires significant development resources. A white-label platform is a complete, ready-to-deploy solution that is simply rebranded. It offers the fastest time to market and lowest technical overhead, but less customization of the core feature set.

Q: How does branding impact patient trust in telehealth? A: Branding is a proxy for trust and consistency. A 2023 Edelman survey on trust in healthcare found that patients are more likely to engage with and trust platforms that have a strong, recognizable brand. In telehealth, where the physical connection is absent, a consistent digital brand experience assures the patient that they are in a secure and professional environment.

A white-label solution allows you to control this experience without the deep investment of building from scratch. Circadify is at the forefront of providing the engine for companies to deliver these services under their own brand. If your team is exploring how to bring camera-based vitals to your users, you can learn more about our partnership options at circadify.com/custom-builds.